Gastrointestinal Safety of Coxibs and Outcomes Studies: What's the Verdict?

This publication has 10 references indexed in Scilit:

• Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
  New England Journal of Medicine, 2000
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects
  The American Journal of Medicine, 2000
• Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial
  Arthritis & Rheumatism, 2000
• Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
  Published by Elsevier ,1999
• Gauging the Impact of Statins Using Number Needed to Treat
  JAMA, 1999
• Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
  JAMA, 1999
• A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
  Gastroenterology, 1999
• Prophylactic aspirin and risk of peptic ulcer bleeding
  BMJ, 1995
• Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
  Annals of Internal Medicine, 1991